Premium
DuPont de Nemours Inc (0A6B)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | Ms. Lori D. KochCEO & Director | -1,56k | 224,42k | Sale to Issuer | 144,09 | 115,06k | -1,34% |
| 2026-06-02 | Ms. Lori D. KochCEO & Director | -86,99 | 12,74k | Vente | 146,46 | 115,06k | -0,08% |
| 2026-05-31 | Ms. Antonella B. FranzenSenior VP & CFO | -519,39 | 74,84k | Sale to Issuer | 144,09 | 22,94k | -2,21% |
| 2026-05-04 | Mr. Edward D. BreenNon-Executive Chairman | -3,85k | 525,45k | Sale to Issuer | 136,62 | 91,33k | -4,04% |
| 2026-05-04 | Ms. Antonella B. FranzenSenior VP & CFO | -81,94 | 11,20k | Sale to Issuer | 136,62 | 23,46k | -0,35% |
| 2026-05-04 | Mr. Erik T. HooverSenior VP & General Counsel | -508,56 | 69,48k | Sale to Issuer | 136,62 | 38,66k | -1,30% |
| 2026-05-04 | Ms. Lori D. KochCEO & Director | -1,02k | 138,82k | Sale to Issuer | 136,62 | 116,61k | -0,86% |
| 2026-05-04 | Mr. Christopher P. RaiaChief HR Officer | -423,46 | 57,85k | Sale to Issuer | 136,62 | 28,64k | -1,46% |
| 2026-02-21 | Mr. Erik T. HooverSenior VP & General Counsel | -860,99 | 130,08k | Sale to Issuer | 151,08 | 39,09k | -2,16% |
| 2026-02-21 | Mr. Jeroen BloemhardPresident of Healthcare & Water Technologies | -342,66 | 51,77k | Sale to Issuer | 151,08 | 8,26k | -3,98% |
| 2026-02-21 | Ms. Antonella B. FranzenSenior VP & CFO | -543,66 | 82,14k | Sale to Issuer | 151,08 | 23,45k | -2,27% |
| 2026-02-21 | Ms. Lori D. KochCEO & Director | -2,71k | 409,07k | Sale to Issuer | 151,08 | 117,28k | -2,26% |
| 2026-02-21 | Mr. Matthew S. AbbottSVP, Chief Information Officer & Chief Procurement Officer | -268,33 | 40,54k | Sale to Issuer | 151,08 | 4,15k | -6,07% |
| 2026-02-21 | Mr. Christopher P. RaiaChief HR Officer | -753,66 | 113,86k | Sale to Issuer | 151,08 | 29,00k | -2,53% |
| 2026-02-21 | Mr. Edward D. BreenNon-Executive Chairman | -2,90k | 438,64k | Sale to Issuer | 151,08 | 94,92k | -2,97% |
| 2026-02-15 | Mr. Edward D. BreenNon-Executive Chairman | -2,52k | 375,30k | Sale to Issuer | 148,79 | 97,83k | -2,51% |
| 2026-02-15 | Mr. Christopher P. RaiaChief HR Officer | -306,66 | 45,63k | Sale to Issuer | 148,79 | 26,45k | -1,15% |
| 2026-02-15 | Ms. Lori D. KochCEO & Director | -656,33 | 97,66k | Sale to Issuer | 148,79 | 93,54k | -0,70% |
| 2026-02-15 | Mr. Erik T. HooverSenior VP & General Counsel | -358,66 | 53,37k | Sale to Issuer | 148,79 | 35,98k | -0,99% |
| 2026-02-15 | Mr. Jeroen BloemhardPresident of Healthcare & Water Technologies | -86,33 | 12,85k | Sale to Issuer | 148,79 | 5,29k | -1,60% |
| 2026-02-15 | Ms. Antonella B. FranzenSenior VP & CFO | -49,33 | 7,34k | Sale to Issuer | 148,79 | 17,38k | -0,28% |
| 2025-12-31 | Mr. Edward D. BreenNon-Executive Chairman | -8,19k | 992,84k | Sale to Issuer | 121,21 | 100,35k | -7,55% |
| 2025-12-31 | Mr. Christopher P. RaiaChief HR Officer | -930,99 | 112,84k | Sale to Issuer | 121,21 | 26,75k | -3,36% |
| 2025-12-31 | Ms. Lori D. KochCEO & Director | -2,23k | 270,86k | Sale to Issuer | 121,21 | 94,20k | -2,32% |
| 2025-12-31 | Mr. Erik T. HooverSenior VP & General Counsel | -1,12k | 135,47k | Sale to Issuer | 121,21 | 36,34k | -2,98% |
| 2025-12-31 | Ms. Antonella B. FranzenSenior VP & CFO | -178,66 | 21,66k | Sale to Issuer | 121,21 | 17,43k | -1,01% |
| 2025-12-17 | Mr. Edward D. BreenNon-Executive Chairman | -2,02k | 246,11k | Sale to Issuer | 121,82 | 108,54k | -1,83% |
| 2025-11-28 | Mr. Erik T. HooverSenior VP & General Counsel | -2,00k | 70,80k | Derivative Exercise and Sale | 84,00 - 119,37 | 37,37k | - |
| 2025-11-28 | Ms. Lori D. KochCEO & Director | -3,00k | 103,27k | Derivative Exercise and Sale | 84,00 - 118,38 | 96,11k | - |
| 2025-11-01 | Mr. Steven P. LarrabeeInitié | -2,13k | 217,82k | Sale to Issuer | 102,36 | 15,17k | -12,30% |
| 2025-09-15 | Mr. Steven P. LarrabeeInitié | -1,33k | 307,92k | Vente | 230,94 | 12,91k | -9,36% |
| 2025-09-15 | Mr. Steven P. LarrabeeInitié | -13,07k | 606,89k | Derivative Exercise and Sale | 160,50 - 231,57 | 12,91k | - |
| 2025-09-05 | Mr. Steven P. LarrabeeInitié | -2,00k | 468,00k | Vente | 234,00 | 14,24k | -12,31% |
| 2025-09-04 | Mr. Steven P. LarrabeeInitié | -8,33k | 261,00k | Derivative Exercise and Sale | 198,18 - 229,50 | 14,24k | - |
| 2025-08-20 | Mr. Edward D. BreenNon-Executive Chairman | -9,37k | 0,00 | Other Disposition | - | 45,76k | -17,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
